Page values for "Oseltamivir"
From Pharmacopedia
More actions
"Medicines" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| generic | String | Oseltamivir |
| brand | String | Tamiflu |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Antivirals|Antiviral]] • [[:Category:Neuraminidase_inhibitors|Neuraminidase inhibitor]] • [[:Category:Anti-influenza_agents|Anti-influenza agent]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-00000E91-QINU`"', '"`UNIQ--vote-00000E92-QINU`"', '"`UNIQ--vote-00000E93-QINU`"' |
| starting_dose | String | Treatment: 75 mg PO BID × 5 days (adult); pediatric weight-based; prophylaxis: 75 mg PO once daily × 7-10 days |
| preparations | String | 30, 45, 75 mg capsules; 6 mg/mL oral suspension |
| fda_max | String | 150 mg/d (treatment) |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral |
| onset | String | Symptom shortening detectable within 24-48 hours of starting (small absolute benefit; ~1 day reduction in symptom duration) |
| duration | String | 12 hours |
| halflife | String | ~6-10 hours (oseltamivir carboxylate, the active metabolite)'"`UNIQ--ref-00000E94-QINU`"' |
| bioavailability | String | ~75% (oral, as the active carboxylate after hepatic esterase activation)'"`UNIQ--ref-00000E95-QINU`"' |
| pregnancy | String | Generally used when influenza treatment is indicated; pregnancy is a recognized risk factor for severe influenza.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US |